About us Contact Terms of Use Data Sources Publications FAQ
FASN logo

FASN

Fatty acid synthase

Expression

StudyTumor samplesMaxQ3Q2Q1MinNormal samplesMaxQ3Q2Q1MinLog2 (T vs N)
Adrenocortical (ACC) 77 3.18 2.53 2.35 2.07 1.66 126 2.99 2.53 2.39 2.25 -0.09 -0.03
Bladder (BLCA) 406 3.29 2.77 2.56 2.40 1.95 9 2.86 2.86 2.41 2.25 2.16 0.16
Breast (BRCA) 1067 3.79 2.94 2.70 2.50 1.63 178 4.02 3.32 2.92 2.63 2.05 -0.22
Cervical (CESC) 297 2.96 2.55 2.38 2.23 1.66 10 3.03 2.62 2.12 2.07 2.03 0.26
Cholangiocarcinoma (CHOL) 36 2.85 2.44 2.28 2.19 1.82 0
Colon (COAD) 443 3.63 2.74 2.60 2.46 1.48 166 3.64 2.40 2.27 2.14 -0.09 0.33
B-cell lymphoma (DLBC) 42 2.51 2.38 2.25 2.12 1.80 337 2.74 2.05 1.85 1.66 0.39 0.40
Esophageal (ESCA) 142 3.02 2.71 2.58 2.43 2.22 271 3.33 2.75 2.64 2.51 -0.09 -0.06
Glioblastoma (GBM) 160 2.68 2.28 2.16 2.07 1.44 214 2.96 2.73 2.65 2.58 -0.09 -0.49
Head and neck (HNSC) 432 3.00 2.62 2.48 2.38 1.78 55 2.79 2.58 2.46 2.32 2.04 0.03